Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
ABSTRACT Kaposi’s sarcoma-associated herpesvirus (KSHV) causes primary effusion lymphoma (PEL). The cellular transcription factor (TF) interferon (IFN) regulatory factor 4 (IRF4) is an essential oncogene in PEL, but its specific role in PEL and how KSHV deregulates IRF4 remain unknown. Here, we repo...
Guardado en:
Autores principales: | Mark Manzano, Thomas Günther, Hyunwoo Ju, John Nicholas, Elizabeth T. Bartom, Adam Grundhoff, Eva Gottwein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7cead49aba0468cb9441394698b0a5e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
por: Marion Gruffaz, et al.
Publicado: (2018) -
Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
por: Marta Maria Gaglia
Publicado: (2021) -
Epidemiology of Kaposi’s Sarcoma
por: Sophie Grabar, et al.
Publicado: (2021) -
Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections
por: Annu Rani, et al.
Publicado: (2021) -
Nanotechnology Frontiers in γ-Herpesviruses Treatments
por: Marisa Granato
Publicado: (2021)